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Background
Ventriculitis is a serious complication of external ventricu-
lar drainage (EVD). Silver-processed catheters (S-PC) are
available that are intended to reduce the risk of infection.
Clinical results of use of S-PC in other settings have been
mixed, with benefit limited to only short-term use [1,2].
Little clinical experience of S-PC for EVD use [3], and no
in-depth laboratory studies have been reported. We there-
fore examined the catheters to determine their antimicro-
bial activity in clinically relevant tests.
Materials and methods
Test bacteria were Staphylococcus epidermidis, Staphylococcus
aureus (MRSA) and Escherichia coli. Catheters (Silverline®)
were purchased from Forth Medical Ltd, UK. For compar-
ison, an in-house processed catheter [4] was tested. Both
contain nanoparticulate silver. Two tests were conducted,
and scanning electron microscopy (SEM) was also carried
out. tK100: This measures the time taken to kill 100% of
bacteria when attached to the catheter material [5]. In vitro
challenge5 determines the ability of the S-PC to resist col-
onisation in flow conditions when repeatedly challenged
with bacteria (as in EVD). In addition, focused ion beam
SEM (FIBSEM) investigated the distribution of silver in
the catheter materials.
Results
At high bacterial inoculum (107 cfu/mL) both S-PCs
failed to show any antimicrobial activity and they were
also not able to resist colonisation. At low inoculum (104
cfu/mL) initial reduction in viability in the tK100 test was
followed by resurgence after 2 days to control levels.
Again, the S-PC became colonised. FIBSEM showed more
silver nanoparticles in the in-house catheter material but
it still did not show superior activity.
Conclusion
S-PC exhibit antimicrobial activity for a few days, after
which they are ineffective in killing attached bacteria. This
may be sufficient to reduce infection rates in very short-
term EVD.
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